News
Stay up to date on topics that are important to Nurse Practitioners.
-
GINA Releases Updated Asthma Guidelines for 2022
The Global Initiative for Asthma (GINA) has updated their guidelines in the 2022 Global Strategy for Asthma Management…
-
Updated COVID-19 Vaccine Recommendations for Children and Test Results for Omicron Subvariant Boosters
In a recent press release, the CDC expanded the use of updated (bivalent) COVID-19 vaccines to children ages…
-
Modified MVA Vaccine Used in Monkeypox Post-Exposure Prophylaxis
The modified vaccinia virus Ankara (MVA), a highly attenuated replication-deficient strain of Vaccinia virus proven to be safe…
-
ICAN Act Proposes Increased Access to NP Services
Introduced to Congress by Rep. Lucille Roybal-Allard (D-CA) and Rep. Dave Joyce (R-OH), bill H.R.8812, colloquially known as…
-
Healthcare Providers Dismiss Challenge to Ruling in No Surprises Act
Introduced in 2019, H.R.3630, or the No Surprises Act, expands restrictions on charging healthcare plan holders out-of-network rates…
-
Cognitive Errors in Clinical Diagnosis Framing and Diagnosis Momentum
The US Preventive Services Task Force’s (USPSTF) recommendation on the use of aspirin to reduce the risk of…
-
Topical Medication for Plaque Psoriasis in Adults Approved by FDA
The FDA approved tapinarof cream 1% (VTAMA), a steroid-free topical cream applied once daily for the treatment of…
-
FDA Approves Two Products for H pylori Infection
The FDA approved vonoprazan, amoxicillin, and clarithromycin (Voquezna Triple Pack) and vonoprazan, amoxicillin (Voquezna Dual Pak) for the…
-
Drug Approved for Recurrent Vulvovaginal Candidiasis
Oteseconazole (Vivjoa) was approved by the FDA to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females…
-
FDA Approves Topical Cream for Inflammatory Rosacea
The FDA approved benzoyl peroxide 5% cream (Epsolay) for adults with inflammatory lesions of rosacea. The medication uses…
-
Nonstimulant Approved for Adult ADHD
The FDA approved the use of viloxazine (Qelbree) extended-release capsules for adults 18 years of age and older…
-
Vaccination Coverage in School Children Fell During the Pandemic
During the 2021-22 school year, vaccination coverage among kindergartners nationwide was lower than during the 2019-20 school year,…
Trending
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
-
The Role of Pharmacogenomics in Precision Mental Healthcare
-
OTC COVID-19 Diagnostic Tests May Have an Extended Shelf Life
-
AANP Offers Resources to Help NPs Detect and Treat Ulcerative Colitis
-
Multistate Outbreak of Salmonella Linked to Cucumbers
-
5 Key Benefits of Getting a Second Certification as a Nurse Practitioner
-
8 Key Tips for Effective Communication During Pediatric ENT Exams
-
Normalizing Anxiety: How NPs Can Guide Patients to Make Healthier Choices
-
CDC Endorses Lowering Pneumococcal Vaccination Age from 65 to 50
-
FDA Proposes Ban on Over-the-Counter Oral Nasal Congestion Medication
-
Using Technology to Combat Drug-Drug Interactions
-
Building a Strong Professional Nursing Network as a New Nurse Practitioner
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.